Skip to main content

bioAffinity Technologies, Inc 8-K, filed Nov 19, 2026

bioAffinity Technologies, Inc. (BIAF)

8-K 2026-11-19 For: 2026-11-19
View Original
Added on November 19, 2026

About this 8-K

bioAffinity Technologies, Inc filed this 8-K on November 19, 2026.

bioAffinity Technologies reported record CyPath Lung testing volume in October 2026, the highest monthly volume for its noninvasive lung cancer test. Q3 CyPath Lung test unit sales rose 109% year to date over 2025, and ordering physicians increased 89%. AI summary

Items reported

  • Item 8.01: Other events
  • Item 9.01: Financial statements and exhibits